Approved Blood Products
Products that are regulated as Biologics License Applications (BLAs), New Drug Applications (NDAS), Premarket Approvals (PMAs), and 510(k)s.
Recommend0 recommendationsPublished in US National Health Agency Sources
Related Articles
KFF Health News’ ‘What the Health?’: American Health Gets a Pink Slip
The Host Julie Rovner KFF Health News @jrovner Read Julie’s stories. Julie Rovner is chief Washington correspondent and host of KFF Health News’ weekly health…
The Colorado Psychedelic Mushroom Experiment Has Arrived
BOULDER, Colo. — Colorado regulators are issuing licenses for providing psychedelic mushrooms and are planning to authorize the state’s first “healing centers,” where the mushrooms…
KFF Health News’ ‘What the Health?’: On Autism, It’s the Secretary’s Word vs. CDC’s
The Host Emmarie Huetteman KFF Health News Emmarie Huetteman, senior editor, oversees a team of Washington reporters, as well as “Bill of the Month” and KFF Health…
Blood Transfusions at the Scene Save Lives. But Ambulances Are Rarely Equipped To Do Them.
One August afternoon in 2023, Angela Martin’s cousin called with alarming news. Martin’s 74-year-old aunt had been mauled by four dogs while out for a…
5 Essential Frameworks for Preventing Violent Child Death
The U.S. has a violent child death problem. Developing strategies to prevent violent child deaths death from firearms and traffic crashes is a demanding task that requires consideration of numerous upstream, interrelated, and tangential issues. To help safety advocates develop strategies to prevent violent child death, we compiled five frameworks to help: Understand and explain …
The post 5 Essential Frameworks for Preventing Violent Child Death appeared first on Salud America.
